TradingAgents AISign inGet started
All stock profiles
CELCNASDAQHealthcare

CELCUITY INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$69.13

-0.25%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze CELC free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-8.0%

3 months

-21.2%

6 months

-45.0%

1 year

-12.4%

Year to date

-30.7%

52-week range

$56.58 – $144.98

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$3.38B

P/E

-14.9

P/B

-264.8

P/S

—

Revenue

$0

Net income

-$226.48M

Diluted EPS

-4.31

Gross margin

—

Net margin

—

Return on equity

-350.80%

Total debt

$754.39M

Cash

$182.05M

Free cash flow

-$192.28M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$78.86M——-$55.56M
Mar 31, 2026$0-$52.84M——-$55.35M
Dec 31, 2025$0-$50.97M——-$36.45M
Sep 30, 2025$0-$43.8M——-$44.91M
Jun 30, 2025$0-$45.27M——-$36.25M
Mar 31, 2025$0-$37M——-$35.91M
Dec 31, 2024$0-$36.65M——-$27.82M
Sep 30, 2024$0-$29.79M——-$20.61M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent CELC news

All market news

No ticker-linked stories are in the current archive.